207 related articles for article (PubMed ID: 38744276)
1. Advancements in clinical RNA therapeutics: Present developments and prospective outlooks.
Saw PE; Song E
Cell Rep Med; 2024 May; 5(5):101555. PubMed ID: 38744276
[TBL] [Abstract][Full Text] [Related]
2. Innovative developments and emerging technologies in RNA therapeutics.
Halloy F; Biscans A; Bujold KE; Debacker A; Hill AC; Lacroix A; Luige O; Strömberg R; Sundstrom L; Vogel J; Ghidini A
RNA Biol; 2022; 19(1):313-332. PubMed ID: 35188077
[TBL] [Abstract][Full Text] [Related]
3. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
4. Recent applications of RNA therapeutic in clinics.
Ha Thi HT; Than VT
Prog Mol Biol Transl Sci; 2024; 203():115-150. PubMed ID: 38359994
[TBL] [Abstract][Full Text] [Related]
5. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Kaczmarek JC; Kowalski PS; Anderson DG
Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
[TBL] [Abstract][Full Text] [Related]
6. Advantages and disadvantages of RNA therapeutics.
Le Huy B; Bui Thi Phuong H; Luong Xuan H
Prog Mol Biol Transl Sci; 2024; 203():151-164. PubMed ID: 38359996
[TBL] [Abstract][Full Text] [Related]
7. RNA-based therapeutics for neurological diseases.
Anthony K
RNA Biol; 2022; 19(1):176-190. PubMed ID: 35067193
[TBL] [Abstract][Full Text] [Related]
8. Insight into RNA-based Therapies for Ovarian Cancer.
Keyvani V; Mahmoudian RA; Mollazadeh S; Kheradmand N; Ghorbani E; Khazaei M; Saeed Al-Hayawi I; Hassanian SM; Ferns GA; Avan A; Anvari K
Curr Pharm Des; 2023; 29(34):2692-2701. PubMed ID: 37916491
[TBL] [Abstract][Full Text] [Related]
9. RNA therapeutics: Molecular mechanisms, and potential clinical translations.
Nguyen TT; Nguyen Thi YV; Chu DT
Prog Mol Biol Transl Sci; 2024; 203():65-82. PubMed ID: 38360006
[TBL] [Abstract][Full Text] [Related]
10. RNA activation: promise as a new weapon against cancer.
Zheng L; Wang L; Gan J; Zhang H
Cancer Lett; 2014 Dec; 355(1):18-24. PubMed ID: 25261049
[TBL] [Abstract][Full Text] [Related]
11. Assembling the RNA therapeutics toolbox.
Teng M; Xia ZJ; Lo N; Daud K; He HH
Med Rev (2021); 2024 Apr; 4(2):110-128. PubMed ID: 38680684
[TBL] [Abstract][Full Text] [Related]
12. RNAi-based therapeutics and tumor targeted delivery in cancer.
Kara G; Calin GA; Ozpolat B
Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
[TBL] [Abstract][Full Text] [Related]
13. Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease.
Schellinger IN; Dannert AR; Mattern K; Raaz U; Tsao PS
Front Cardiovasc Med; 2021; 8():571076. PubMed ID: 33937351
[TBL] [Abstract][Full Text] [Related]
14. RNA therapeutics for neurological diseases.
Brentari I; Zadorozhna M; Denti MA; Giorgio E
Br Med Bull; 2023 Sep; 147(1):50-61. PubMed ID: 37210633
[TBL] [Abstract][Full Text] [Related]
15. DNA-based therapeutics and DNA delivery systems: a comprehensive review.
Patil SD; Rhodes DG; Burgess DJ
AAPS J; 2005 Apr; 7(1):E61-77. PubMed ID: 16146351
[TBL] [Abstract][Full Text] [Related]
16. Discovery platforms for RNA therapeutics.
Ciucci G; Braga L; Zacchigna S
Br J Pharmacol; 2024 May; ():. PubMed ID: 38760893
[TBL] [Abstract][Full Text] [Related]
17. Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art.
Rhym LH; Anderson DG
Med; 2022 Mar; 3(3):167-187. PubMed ID: 35590191
[TBL] [Abstract][Full Text] [Related]
18. Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs.
Bartolucci D; Pession A; Hrelia P; Tonelli R
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890348
[TBL] [Abstract][Full Text] [Related]
19. RNA Therapeutics Are Stepping Out of the Maze.
Agrawal S
Trends Mol Med; 2020 Dec; 26(12):1061-1064. PubMed ID: 32988738
[TBL] [Abstract][Full Text] [Related]
20. Multimeric RNAs for efficient RNA-based therapeutics and vaccines.
Kim D; Han S; Ji Y; Moon S; Nam H; Lee JB
J Control Release; 2022 May; 345():770-785. PubMed ID: 35367477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
